FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Industries

  • Medicine ‎1
    • Tissue Engineering ‎1

Contact Info

Location

Ablynx

  • 1Product
  • 1Types
  • 1Industry

About Company

Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments. Today, the Company has approximately 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease.

Products

MEDICINE - TISSUE ENGINEERING   |  ANTIBODY

Nanobodies

Application :

Medicine

Analytical Reports